Latest filing published 03 Mar 2021 for Global Blood Therapeutics, Inc., €48k.
Filing timeline
BuySaleInsider track record
Brian Edwin Cathers: trading record in brief
Brian Edwin Cathers appears in our data through filings on Global Blood Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 31 January 2020 to 1 March 2021, the count stands at 14 filings.
No open-market purchase appears, only 1 sale worth €118k. The rest of the record consists of 8 share grants and 5 option exercises.
Most recently, on 3 March 2021, the filings show a share grant worth €48k in Global Blood Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brian Edwin Cathers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,297 shares@ US$44.489.0% of flowCommon StockSEC:0000899243-21-009561:1
- 3,750 sharesCommon StockSEC:0000899243-21-009561:0
- 267 shares@ US$41.171.7% of flowCommon StockSEC:0000899243-21-004734:0
- 1,178 shares@ US$49.499.0% of flowCommon StockSEC:0000899243-21-004734:2
- 3,020 sharesCommon StockSEC:0000899243-21-004734:1
- 3,750 sharesCommon StockSEC:0000899243-20-024183:0
- 1,551 shares@ US$60.4518.4% of flowCommon StockSEC:0000899243-20-024183:1
- 2,200 shares@ US$63.7727.7% of flowCommon StockSEC:0000899243-20-023299:0
- 290 shares@ US$41.172.4% of flowCommon StockSEC:0000899243-20-021333:0
- 1,045 shares@ US$67.4813.9% of flowCommon StockSEC:0000899243-20-021333:2
- 3,020 sharesCommon StockSEC:0000899243-20-021333:1
- 2,594 shares@ US$63.9635.3% of flowCommon StockSEC:0000899243-20-007086:1
- 7,500 sharesCommon StockSEC:0000899243-20-007086:0
- 273 shares@ US$41.172.4% of flowCommon StockSEC:0000899243-20-003040:0
14 of 14 declarations
